Fig. 11From: High-coverage targeted lipidomics could reveal lipid alterations and evaluate therapeutic efficacy of membranous nephropathyROC curve for prediction of therapeutic effect of TCM. (Model 1: Adjusted for age, gender, hypertensive, diabetes, uric acid, creatinine, albumin, 24hpro; Model 2: Adjusted for Model 1, HDL, LDL, TG, CHOL; Model 3: Adjusted for Model2, TG56:2-FA20:0, TG56:2-FA20:1, TG56:3-FA20:0, TG56:5-FA20:2)Back to article page